Deals

three triple doors opportunity cracked open ajar
Biotech

89bio was left between a Roche and a hard place in buyout talks

Over three years, 89bio signed confidentiality agreements with 14 biopharmas as it advanced its MASH candidate.
Nick Paul Taylor Oct 2, 2025 9:55am
Novo

Novo Nordisk vs. KBP: From $1.3B deal to legal battlefield

Oct 2, 2025 3:00am
A ballpoint pen rests on top of a stack of documents ready for signing

Kyorin pens $105M pact for Japan rights to Hinge's lupus drug

Oct 1, 2025 6:40am
cardiovascular disease

Novo calls off $598M Heartseed collab, citing 'strategic reviews'

Sep 30, 2025 1:55pm
Metallic arrow symbols which are illuminated by blue and magenta lights merge on blue and magenta b

Barinthus enters reverse merger with metabolic disease biotech

Sep 30, 2025 10:39am
direction arrow

Anaptys plans to split into 2 businesses

Sep 30, 2025 9:35am